Outcome after coronary artery bypass grafting

Size: px
Start display at page:

Download "Outcome after coronary artery bypass grafting"

Transcription

1 ICU Admission Score for Predicting Morbidity and Mortality Risk After Coronary Artery Bypass Grafting Thomas L. Higgins, MD, Fawzy G. Estafanous, MD, Floyd D. Loop, MD, Gerald J. Beck, PhD, Jar-Chi Lee, MS, Norman J. Starr, MD, William A. Knaus, MD, and Delos M. Cosgrove III, MD Departments of Cardiothoracic Anesthesia, Thoracic and Cardiovascular Surgery, and Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, Ohio Background. This study was performed to develop an intensive care unit (ICU) admission risk score based on preoperative condition and intraoperative events. This score provides a tool with which to judge the effects of ICU quality of care on outcome. Methods. Data were collected prospectively on 4,918 patients (study group n 2,793 and a validation data set n 2,125) undergoing coronary artery bypass grafting alone or combined with a valve or carotid procedure between January 1, 1993, and March 31, Data were analyzed by univariate and multiple logistic regression with the end points of hospital mortality and serious ICU morbidity (stroke, low cardiac output, myocardial infarction, prolonged ventilation, serious infection, renal failure, or death). Results. Eight risk factors predicted hospital mortality at ICU admission, and these factors and five others predicted morbidity. A clinical score, weighted equally for morbidity and mortality, was developed. All models fit according to the Hosmer-Lemeshow goodness-of-fit test. This score applies equally well to patients undergoing isolated coronary artery bypass grafting. Conclusions. This model is complementary to our previously reported preoperative model, allowing the process of ICU care to be measured independent of the operative care. Sequential scoring also allows updated prognoses at different points in the continuum of care. (Ann Thorac Surg 1997;64:1050 8) 1997 by The Society of Thoracic Surgeons Outcome after coronary artery bypass grafting (CABG) is determined by the preoperative status of the patient, as well as by technical factors in the operating room and intensive care unit (ICU). Preoperative risk stratification in the cardiac surgical population consistently identifies advanced age, emergency status, left ventricular dysfunction, a previous heart operation, diabetes, female sex, small body size, and renal disease as factors that affect outcome [1 5]. However, morbidity and mortality after CABG are also influenced by surgical and anesthetic techniques [6, 7], including time on cardiopulmonary bypass [7], completeness of revascularization [8], efficacy of myocardial protection [9], hemodynamic management [10], and unforeseen events in the operating room. The patient s prognosis at arrival to the ICU may differ from the preoperative prognosis. In the present study, we evaluated the relative contribution of preoperative condition, operating room events, and physiologic measurements at ICU admission to outcome and describe a risk stratification score based on a patient s status at ICU admission. Accepted for publication April 7, Address reprint requests to Dr Estafanous, Division of Anesthesiology and Critical Care, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH Material and Methods We prospectively collected data on 4,918 consecutive adult patients undergoing CABG between January 1, 1993, and March 31, Preoperative data were collected by resident physicians, and ICU admission data were collected by trained physician assistants. Data collected during the first 15 months (n 2,793) were used to develop the model, and data collected during the next 12 months (n 2,125) were used to validate the model. Patients undergoing repeat operation, simultaneous carotid endarterectomy, or repair or replacement of the mitral or aortic valve (or both) were included in the study, because these combined CABG patients represent a large (27%) and growing part of our surgical population. A separate analysis was also conducted on the subset of patients (n 2,035; 73% of the developmental data set) undergoing isolated coronary revascularization. Six patients underwent both a primary and a repeat revascularization procedure during the study period, but only the first operation was considered for analysis. The reliability of data collection was assessed by comparing the data with chart review of a random subset. This review showed a relevant agreement of 98% to 100% of patients for each variable used in the final models. We chose more than 100 risk factors from the literature, our clinical experience, and our own work [1, 8, 11] and 1997 by The Society of Thoracic Surgeons /97/$17.00 Published by Elsevier Science Inc PII S (97)

2 Ann Thorac Surg HIGGINS ET AL 1997;64: ICU ADMISSION RISK SCORE 1051 examined the influence of each on outcome at discharge. Emergency cases were those characterized by unstable angina, unstable hemodynamics, or ischemic valvular dysfunction that could not be controlled medically. Left ventricular function was categorized as normal (ejection fraction [EF] 0.60], mildly impaired (EF 0.50 to 0.59), mildly to moderately impaired (EF 0.46 to 0.49), moderately impaired (EF 0.41 to 0.45), moderately to severely impaired (EF 0.36 to 0.40), or severely impaired (EF 0.35) based on the cardiologist s evaluation of the ventriculogram at cardiac catheterization or by echocardiography if a ventriculogram was not recorded. Diabetes or chronic obstructive pulmonary disease was diagnosed only if the patient had a history of the condition and was maintained on appropriate medications. Valvular pathology was evaluated by stenosis versus regurgitation and repair versus replacement. Cardiopulmonary bypass time was the total of all bypass runs if a second or subsequent period of bypass was conducted. The need for a second or greater bypass run was also considered as a separate factor in the analysis. Morbidity was defined as the presence of one or more of the following during hospitalization: (1) cardiac complication: low cardiac output (sustained cardiac index 1.8 L min 1 m 2 despite adequate preload and inotropic support) or myocardial infarction documented by electrocardiography and enzyme criteria and that required the use of an intraaortic balloon pump (IABP) or a ventricular assist device (IABP and assist devices were resorted to when vasoactive drug support failed to achieve a cardiac index 2 L/m or mean arterial pressure 60 mm Hg without significant side effects (eg, persistent ischemia, arrhythmias); (2) prolonged ventilatory support: mechanical ventilation for 72 hours or more; (3) central nervous system complication: focal brain lesion confirmed by clinical findings, computed tomographic scan, or both, or diffuse encephalopathy with more than 24 hours of severely altered mental status, failure to awaken postoperatively, or both; (4) renal failure: urine output of 400 ml/24 hours, institution of dialysis, or both; (5) serious infection: culture-proven pneumonia (blood or sputum), mediastinitis, wound infection, sepsis syndrome, or septic shock; or (6) death, because early hospital death might preclude the diagnosis of other morbidities. Mortality included all deaths during the hospitalization for the operation, regardless of length of stay. Development of the Logistic Regression Model The association of each factor with morbidity and mortality was evaluated using a 2 test or Fisher s exact test for categoric variables and Student s t test for continuous variables. Because of the large number of variables analyzed, only the most significant are presented in Tables 1 and 2. Continuous variables significantly related to outcome were plotted using a locally weighted smoothing scatterplot technique [12] to assess linearity on the logit scale. If the relationship to risk was linear, the factor was entered into the model as a continuous variable. If the relationship to risk was not linear, appropriate cut points were determined from the locally weighted smoothing scatterplots to divide the distribution of values into categories. Locally weighted smoothing scatterplots were also used to divide variables that were continuous in the logistic models into categories for use in a clinical risk stratification score (see below). Factors considered for the multiple logistic regression included only those that were significant (p 0.05) by univariate analysis, had a prevalence of at least 2% for categoric variables, and that indicated a patient condition rather than a therapeutic decision. Interactions of potentially related variables, such as low cardiac index and the use of an IABP, were also evaluated. The logistic regression analyses used a forward stepwise selection procedure with p values of 0.15 to enter and 0.05 to remain in the model. Two models were developed: one each for mortality and morbidity. The number of terms allowed in a logistic model was limited to 10% of the number of outcome events, with only the most significant factors included to avoid overfitting the models [13]. The goodness of fit of each final logistic model was evaluated using the Hosmer-Lemeshow 2 statistic [14]. In the event of a low number of expected events, the lowest deciles were combined for statistical analysis, with appropriate reduction in the degrees of freedom. Receiver operating characteristic curves were used to generate a C-statistic (area under the curve) to measure and compare the accuracy of the models [15, 16]. C-statistic values closer to 1.0 indicate better discrimination by the model. Development of the Clinical Model and Risk Stratification Score A clinical model was created by first categorizing continuous predictors in the logistic regression models by using the locally weighted smoothing scatterplot procedure to identify cut points and then refitting the logistic models using all predictors as categoric variables. For example, for cardiopulmonary bypass time the cut point of 160 minutes was based on the much higher mortality above this value in the locally weighted smoothing scatterplots. Cut points were not based on being one or two standard deviations above the mean. Then a numeric score was calculated by summing the regression coefficient estimates of the logistic models for morbidity and mortality, multiplying by 2, and then rounding to the nearest integer to produce a clinical model that equally weights mortality and morbidity. This clinical model was evaluated for its goodness of fit and discrimination on the developmental data set, the subset of patients who underwent isolated coronary bypass without other simultaneous procedures, and the validation data set. Individual levels of morbidity and mortality risk were then combined into five levels of risk to facilitate the application of the scoring system when smaller numbers of patients are available, as might be seen in quarterly analysis or at institutions with smaller surgical volumes. The observed values in the validation set were then compared with the 95% confidence intervals of the predicted values generated from the developmental data set.

3 1052 HIGGINS ET AL Ann Thorac Surg ICU ADMISSION RISK SCORE 1997;64: Table 1. Selected Categoric s and Univariate Analysis Occurrence (%) Mortality Morbidity Odds Ratio p Value Odds Ratio p Value Sex (female) History of COPD/asthma History of pulmonary hypertension History of congestive heart failure History of dysrhythmias History of vascular disease or operation History of carotid disease or CVA Left main stenosis 70% Endocarditis Preop IABP Recent myocardial infarction ( 3 mo) Diabetes mellitus (requiring medication) One prior heart operation Two or more prior heart operations Preop LVEF Emergency procedure One or two IMA grafts IABP after bypass AV replacement or repair MV replacement MV repair TV replacement or repair Aortic operation in addition to CABG OR HR 100 beats/min OR CI 2.1 L min 1 m Transfused more than 2 units in OR Urine output in OR 500 ml More than one CPB run More than one cross-clamp ICU admit HR 100 beats/min ICU admit MAP 60 mm Hg ICU admit CVP 17 mm Hg ICU admit PA diastolic 17 mm Hg ICU admit CI 2.1 L min 1 m ICU admit inotrope ICU admit pressor ICU admit antiarrhythmic ICU arrival MAP 70 mm Hg AV atrial valve; CABG coronary artery bypass grafting; CI cardiac index; COPD chronic obstructic pulmonary disease; CPB cardiopulmonary bypass; CVA cerebrovascular accident; CVP central venous pressure; HR heart rate; IABP intraaortic balloon pump; ICU intensive care unit; IMA internal mammary artery; LVEF left ventricular ejection fraction; MAP mean arterial pressure; MV mitral valve; PA pulmonary artery pressure; OR operating room; TV tricuspid valve. Most statistical analyses were performed with SAS version 6.0 (Statistical Analysis Systems, Cary, NC). The receiver operating characteristic analyses used programs developed by Metz and associates [15, 16]. Results Univariate risk factors for morbidity and mortality are presented in Table 1 (categoric variables) and Table 2 (continuous variables). Selected variables that were not statistically significant by univariate analysis included low urine output in the operating room, history of chronic obstructive pulmonary disease requiring medication, history of renal failure requiring dialysis, chronic hypertension, race other than white, prior carotid operation, prior lung operation, and preoperative use of antiarrhythmics or calcium channel antagonists. Ventricular aneurysectomy or carotid operation in addition to CABG also did not achieve statistical significance. Fifty-eight variables qualified for entry into the multiple logistic regression analysis. The logistic regression models for mortality and morbidity are presented in Tables 3 and 4. These models were fit on 2,440 patients having complete data on these variables. To avoid over-

4 Ann Thorac Surg HIGGINS ET AL 1997;64: ICU ADMISSION RISK SCORE 1053 Table 2. Selected Continuous s: Univariate Analysis Mean Value SD Mortality p Value Morbidity p Value Age (y) Preop hematocrit (%) Preop creatinine (mg/dl) Preop albumin (mg/dl) Preop bilirubin (mg/dl) Height (cm) Weight (kg) Body surface area (Dubois method; m 2 ) Preop arterial PCO 2 (mm Hg) Preoperative cardiac index (L min 1 m 2 ) Cross clamp time (total minutes) CBP time (total minutes) Urine output in OR (ml kg 1 h 1 ) ICU arrival FIO ICU arrival ph (arterial blood gas, units) ICU arrival PCO 2 (arterial blood gas, mm Hg) ICU arrival PO 2 (arterial blood gas, mm Hg) ICU arrival HCO 3 (arterial blood gas, mm Hg) ICU arrival core temp (degrees) ICU arrival HR (beats/min) ICU arrival MAP (mm Hg) ICU arrival CVP (mm Hg) ICU arrival PA systolic (mm Hg) ICU arrival PA diastolic (mm Hg) ICU arrival CI (L min 1 m 2 ) ICU arrival A-a O 2 gradient (mm Hg) ICU hematocrit (%) ICU K (meq/l) ICU glucose (mg/dl) ICU WBC (/ L) 12, , A-a O 2 gradient alveolar-arterial oxygen gradient; CI cardiac index; CPB cardiopulmonary bypass; CVP central venous pressure; FiO 2 fraction of inspired oxygen; HR heart rate; ICU intensive care unit; MAP mean arterial pressure; OR operating room; PA pulmonary artery pressure; PCO 2 carbon dioxide tension; PO 2 oxygen tension; SD standard deviation; WBC white blood cell count. fitting, the mortality model was restricted to the first eight significant factors, because there were only 78 deaths. Significant factors that would have been entered into the model without this restriction were central venous pressure and mean arterial pressure values at ICU admission, and a history of congestive heart failure. Table 3. Intensive Care Unit Admission Mortality Model Regression Coefficient Standard Error Odds Ratio 95% Confidence Interval Intercept Use of IABP After CPB Cardiac index at ICU admission 0.64 a Age per decade Preoperative serum albumin (mg/dl) 1.74 a History of peripheral vascular disease or interventions CPB time per 10 minutes HR 100 beats/min at ICU admission Arterial bicarbonate at ICU Admission (m/mol) 0.17 a a Negative values in the regression coefficient imply that lower values of the variable increase mortality. CPB cardiopulmonary bypass; HR heart rate; IABP intraaortic balloon pump; ICU intensive care unit.

5 1054 HIGGINS ET AL Ann Thorac Surg ICU ADMISSION RISK SCORE 1997;64: Table 4. Intensive Care Unit Admission Morbidity Model Regression Coefficient Standard Error Odds Ratio 95% Confidence Interval Intercept Body surface area (m 2 ) 0.90* prior heart operations History of peripheral vascular disease or interventions Age per decade Preoperative serum creatinine (mg/dl) Preoperative serum albumin (mg/dl) 0.90* CPB time per 10 minutes Use of IABP after CPB A-a gradient at ICU admission per 10 mm Hg HR 100 beats/min at ICU admission Cardiac index at ICU admission (L min 1 m 2 ) 0.47 a CVP at ICU admission (mm Hg) Arterial bicarbonate at ICU admission (mmol/l) 0.13 a a Negative values in the regression coefficient imply that lower values of the variable increase morbidity. A-a alveolar-arterial; CPB cardiopulmonary bypass; CVP central venous pressure; HR heart rate; IABP intraaortic balloon pump; ICU intensive care unit. No such limits applied to the morbidity model, which has 13 factors, including all eight factors in the mortality model, plus central venous pressure and alveolar arterial gradient at ICU admission, preoperative serum creatinine level, reoperation status, and body surface area. The risk stratification score (Table 5) incorporates all factors affecting morbidity and mortality from the multiple logistic regression models, divides continuous variables into categories, and assigns integer point values of 1 to 7 on the basis of the logistic regression coefficients. A patient s stratification score is obtained by adding the point values from Table 5, which can then be related to mortality (Fig 1) and morbidity (Fig 2). In the total population, the mortality rate was 3.1% and the morbidity rate was 10.4%, but rates vary by ICU risk stratification score. The categorization of risk levels was made on the basis of similar outcomes. For example, patients with a score less than 5 at ICU admission are at risk of less than 1% for mortality and less than 5% for morbidity. The risks of mortality and morbidity increase with higher scores (see Figs 1, 2). Receiver operating characteristic curves were generated for all models. The C-statistics (areas under the curves) reflecting mortality for the logistic regression mortality and clinical models were 0.86 and 0.87, respectively, which were not significantly different from each other. The C-statistics reflecting morbidity for the logistic regression morbidity and clinical model were 0.82 and 0.80, respectively, reflecting slightly better discrimination (p 0.02) for the logistic regression model. Applying the clinical model to patients undergoing isolated CABG generated a C-statistic of 0.87 for mortality and 0.82 for morbidity. Using the clinical model, observed outcomes in patients in the validation data set fell within the 95% confidence intervals predicted by the developmental data set (see Figs 1, 2). Applying the clinical model to patients in the validation data set produced C-statistics of 0.85 for mortality and 0.82 for morbidity. Hosmer- Lemeshow goodness of fit determined that all logistic and clinical models calibrate well. The accuracy and goodness of fit of both the logistic and clinical models were very similar indicating that the clinical severity score, although not a probability, can be useful in categorizing risks of mortality and morbidity in CABG patients. Comment Preoperatively, patients undergoing open heart operations should be expected to be concerned about the possible outcome of the operation, including morbidity and mortality. Payors and health providers need similar information. Several preoperative risk status models have been developed to predict outcome after coronary artery operations [1 5]. These models all predict mortality, and possibly morbidity, with good accuracy but they also have shortcomings [17]. The patient s physiologic response to the operation and anesthesia cannot always be predicted from preoperative information. Unexpected intraoperative events, management of anesthesia [10], efficacy of myocardial preservation [9], completeness of myocardial revascularization, and uneventful reoperation can neutralize or amplify preoperative risk. All these factors can affect the prognosis. Thus reevaluation and assessment of a patient s condition at ICU admission complements the preoperative evaluation and allows for a proactive ICU management plan and better prediction of outcome. Previous work from our group [1] identified 13 preoperative risk factors for morbidity and mortality after CABG. Four of these factors are also significant in the ICU admission models: preoperative serum creatinine

6 Ann Thorac Surg HIGGINS ET AL 1997;64: ICU ADMISSION RISK SCORE 1055 Table 5. Intensive Care Unit Risk Stratification Score Value Preoperative Factors Small body size (BSA 1.72 m 2 ) 1 Prior heart operation One 1 Two or more 2 History of operation or angioplasty 3 for peripheral vascular disease Age 70 years 3 Preoperative creatinine 1.9 mg/dl 4 Preoperative albumin 3.5 mg/dl 5 Intraoperative factors CPB time 160 minutes 3 Use of IABP after CPB 7 ICU admission physiology A-a O 2 gradient 250 mm Hg 2 Heart rate 100 beats/min 3 Cardiac index 2.1 L min 1 m 2 3 CVP 17 mm Hg 4 Arterial bicarbonate 21 mmol/l 4 A-a alveolar-arterial; BSA body surface area; CPB cardiopulmonary bypass; CVP central venous pressure; IABP intraaortic balloon pump; ICU intensive care unit. Fig 1. Mortality by intensive care unit (ICU) admission risk group. Risk is estimated by summing the individual elements in Table 5. Results are displayed for the developmental set ( ) and the prospective validation set ( ). All observed (validation) values fall within the 95% confidence intervals established from the developmental set. Fig 2. Morbidity by intensive care unit (ICU) admission risk group. See legend for Figure 1. level, age, prior cardiac operation, and a history of vascular disease. Data on serum albumin level, a significant factor in the ICU model, were not available for consideration in our preoperative risk model (Table 6). However, preoperative hematocrit, used previously as a measure of chronic disease, appears to account for some of the same information as albumin (Pearson correlation coefficient between hematocrit and serum albumin 0.43). If serum albumin level is not considered as a variable, hematocrit would appear as a fifth factor common to the preoperative and ICU admission models. Several other factors in the preoperative risk score did not appear in the ICU admission score because these preoperative risk factors are managed during the operation or are subsumed by other scoring elements. For example, preoperative left ventricular dysfunction is an important preoperative risk factor [1 5, 18 20] and it appears as a univariate risk factor in the present study, but it did not remain in the ICU admission logistic regression models. Preoperative ventricular dysfunction (EF 0.35) is not associated with low cardiac index on arrival to ICU (p 0.50), but it is highly associated (p ) with the use of IABP after bypass. The use of IABP after bypass thus becomes a better prognostic indicator than preoperative left ventricular dysfunction. This study also confirmed that intraoperative events such as cardiopulmonary bypass time and the use of an IABP are as important as preoperative risk factors in predicting outcome. Cardiopulmonary bypass time was analyzed as a continuous factor in the logistic model and it showed increase in mortality and morbidity with increasing time. We use 160 minutes as the cutpoint, which is 1.58 times the median time (101 minutes). The 160 minutes represents the 89.1 percentile and was chosen based on locally weighted smoothing scatterplot curve analysis demonstrating a sharp increase in poor outcome above this value. Emergency procedures are significant preoperative predictors of poor outcome, but were not significant in the ICU admission logistic regression models. Emergency patients are more likely to have other risk factors on ICU arrival such as low cardiac index, decreased serum albumin, higher alveolar arterial oxygen gradient, elevated central venous pressure, and tachycardia. These

7 1056 HIGGINS ET AL Ann Thorac Surg ICU ADMISSION RISK SCORE 1997;64: Table 6. Preoperative Severity Score Score Emergency 6 Serum creatinine 1.9 mg% 4 Serum creatinine mg% 1 Severe LV dysfunction 3 Prior cardiac operation 3 Operative mitral valve insufficiency 3 Age 75 years or older 2 Age 65 to 74 years 1 Prior vascular surgery 2 COPD on medication 2 Anemia (Hct 34%) 2 Operative aortic stenosis 1 Weight 65 kg 1 Diabetes on medication 1 Cerebrovascular disease 1 Maximum score 31 Clinically relevant range 0 to 13 COPD chronic obstructive pulmonary disease; Hct hematocrit; LV left ventricular. Reprinted with permission from JAMA 1992;267:2345 (copyright 1992, American Medical Association). were included in the logistic and clinical models. It is clear that scoring based on physiologic variables is more patient specific and is preferable to the term emergency, a definition that might vary between institutions. Several other physiologic measurements at ICU admission are predictors of outcome in this study, namely alveolar arterial oxygen gradient, heart rate, cardiac index, central venous pressure, and arterial bicarbonate. The use of physiologic measurements to predict outcome was pioneered by the APACHE prognostic system [21] and successfully predicts mortality, resource use, and ICU length of stay in CABG patients [22]. The present study confirms the importance of physiologic measurements at ICU admission as outcome predictors. Some of the physiologic variables (such as body temperature and hematocrit) scored by APACHE-III, a benchmark for determining outcome in noncardiac intensive care units, may have a different relationship with outcome in CABG patients [21]. During cardiopulmonary bypass most patients are cooled systematically and their temperature at ICU admission can be less than 37 C. This does not reflect a pathologic status. Hemodilution is now a routine practice in cardiac surgery. Immediate postoperative hematocrit of 24% or greater is generally considered adequate. Experimental studies by our group [23] and our clinical experience demonstrated that hematocrit greater than 28% is necessary to maintain hemodynamic stability in patients with impaired ventricular function. In the present study, patients with hematocrit levels of 24% or greater were more likely to require transfusion in the operating room (p 0.001). Therefore low hematocrit values (about 24%) are not necessarily a marker of increased risk in CABG patients, although it has predictive ability in other ICU patients. This ICU risk stratification score relates to both morbidity and mortality as end points. Statistically, the contribution of patient management to outcome is more evident when the end point occurs more frequently. In this study the incidence of morbidity (10.4%) is higher than the incidence of overall mortality (3.1%). Therefore, morbidity better reflects the ICU and hospital length of stay and cost. Although many of the risk factors predict both morbidity and mortality, the logistic regression models demonstrate that some of the risk factors for mortality and morbidity were different. The clinical model included the most significant factors that encompassed both outcomes, and can be a useful tool for benchmark comparisons. This ICU admission model is part of a sequential evaluation of the probability of morbidity or mortality. In the present study, we investigated the sequential relationship of how the prognosis of mortality changes during the perioperative period (Fig 3). In patients with preoperative risk scores of 6 or less (n 2,118) the mortality was 2.3%; of these patients 97% had an ICU admission score of 14 or less with a mortality rate of 1.7%. The other 3% had an ICU admission score greater than 14 with a mortality of 19.4%. In the 318 patients with preoperative risk scores of 7 or greater the mortality was 9.4%. However 80% of these patients (n 254) had an ICU score of 14 or less and a mortality rate of 4.3%. The remaining 20% (n 64) of these patents were admitted to the ICU with a score greater than 14 and had a mortality rate of 29.7%. This sequential analysis demonstrates that the ICU Fig 3. Sequential analysis of mortality risk in cardiac surgical patients. Use of preoperative and intensive care unit (ICU) risk stratification scores for sequential analysis of mortality risk. A preoperative score of 7 was used as the cut point between a low and high risk. An ICU admission score of 14 was used as the cut point to determine the level of risk.

8 Ann Thorac Surg HIGGINS ET AL 1997;64: ICU ADMISSION RISK SCORE 1057 admission scoring model identifies patients with high risk of mortality based on postoperative status who were not identified by preoperative scoring alone. Thus discrimination of outcome based on ICU admission stratification is superior to stratification by preoperative status alone. This is borne out by comparison of receiver operating characteristic curves. In preoperative models for cardiac surgery, the area under the receiver operating characteristic curve (the C-statistic) for mortality prediction ranges from 0.74 to 0.83 [1, 4, 5, 17]. The comparable C-statistic for the ICU admission clinical model is Similar results (a C-statistic of 0.85) have been reported for APACHE-III in the cardiac surgical setting [22]. However, caution should be exercised in comparing C-statistics across different populations in different studies, because C-statistics in independent, prospective validation studies are often lower [17]. Also, a prospective multicenter study for validation of this ICU model is necessary to establish a benchmark. It will also enhance the management strategies that improve outcome on the high-risk patients [9]. Limitations of the Study This study was performed in a single hospital with a high surgical volume and may not reflect the experience of hospitals performing a small number of CABG operations, as outcome can be related to surgical volume [24]. The model was developed and validated prospectively on large groups of patients; therefore, this score will be useful in comparing outcomes in groups of patients. The use of the model for risk prediction in individual patients can be limited. A logistic regression model cannot include every risk factor, especially factors with low incidence. In the present study, factors such as asystolic arrest, open chest on the day of operation, and tricuspid valve operation were highly significant univariate predictors of poor outcome but of such low prevalence (all 0.8%) that they were not retained in the logistic regression models. There were too few outcomes to develop reliable univariate risk estimates for several predictive factors, such as aortic valve repair, ventricular aneurysm repair, or carotid repair performed concurrently with CABG. The simplification of continuous variables into scoring categories introduces large increments or steps of risk in the clinical model that contrasts with the gradual increases apparent in the logistic regression models. For example, creatinine clearance and renal reserve differ only slightly between a patient with a preoperative creatinine level of 1.9 mg/dl and one with a creatinine level of 1.8 mg/dl, but the clinical scoring system assigns increased risk to one and not the other. Conclusions The ability to predict outcome with an ICU admission score enhances preoperative risk stratification and allows sequential prognosis, isolation of preoperative status from operative care in outcome assessment, and the ability to use a revised prognosis at ICU admission to plan further medical care and interventions. Morbidity and mortality in CABG patients are influenced by factors unique to the cardiac surgical patient, which may limit the applicability of general scoring systems to this specialized population. This ICU admission clinical model assesses the impact of comorbid disease, and includes factors that may not be adequately assessed in models derived from discharge or other administrative data [25 27]. The impact of ICU admission physiology and operative events should be considered in assessing postoperative outcome. Partial support for this study was provided by APACHE Medical Systems. References 1. Higgins TL, Estafanous FG, Loop FD, et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA 1992;267: Paiement B, Pelletier C, Dyrda I, et al. A simple classification of the risk in cardiac surgery. Can Anaesth Soc J 1983;30: Hattler BG, Madia C, Johnson, et al. Risk stratification using The Society of Thoracic Surgeons program. Ann Thorac Surg 1994;58: Hannan EL, Kilburn H, O Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State: an analysis of risk factors and hospital mortality rates. JAMA 1990;264: O Connor GT, Plume SK, Olmstead EM. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Circulation 1992;85: Kouchoukos NT, Oberman A, Kirlin JW, et al. Coronary bypass surgery: analysis of factors affecting hospital mortality. Circulation 1980;72(Suppl 1): Merry AF, Ramage MC, Whitlock RML, et al. First-time coronary artery bypass grafting: the anaesthestist as a risk factor. Br J Anaesth 1992;68: Cosgrove DM, Loop FD, Lytle BW, et al. Primary myocardial revascularization. Trends in surgical mortality. J Thorac Cardiovasc Surg 1984;88: Loop FD, Higgins TL, Panda R, et al. Myocardial protection during cardiac operations. J Thorac Cardiovasc Surg 1992; 104: Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology 1985;62: Higgins TL, Starr NJ. Risk stratification and outcome assessment of the adult cardiac surgical patient. Semin Thorac Cardiovasc Surg 1991;3: Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74: Harrell FE Jr, Lee KL, Matchar DB, Reichert TA. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treatment Rep 1985;69: Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Communication of Statistics: Theory and Methods 1980;A9: Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8: Metz CE, Wang PL, Kronman MB. A new approach for testing the significance of differences between ROC curves for correlated data. In: Decornick F, ed. Information processing in medical imaging. The Hague: Nijhoff, Orr RK, Maini BS, Sottile FD, Dumas EM, O Mara P. A comparison of four severity-adjusted models to predict mortality after coronary artery bypass graft surgery. Arch Surg 1995;130:301 6.

9 1058 HIGGINS ET AL Ann Thorac Surg ICU ADMISSION RISK SCORE 1997;64: Pierpont GL, Kruse M, Ewald S, Weir EK. Practical problems in assessing risk for coronary artery bypass grafting. J Thorac Cardiovasc Surg 1985;89: Kennedy JW, Kaiser GC, Fisher LD, et al. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg 1980;80: Goenen M, Jacquemart JL, Galvez S, et al. Preoperative left ventricular dysfunction and operative risks in coronary bypass surgery. Chest 1987;92: Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100: Becker RB, Zimmermann JE, Knaus WA, et al. The use of APACHE III to evaluate ICU length of stay, resource use, and mortality after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1995;36: Mossad E, Estafanous F. Blood use in cardiac surgery and the limitations of hemodilution. Curr Opin Cardiol 1995;10: Flood AB, Scott WR, Ewy W. Does practice make perfect? Part I: The relation between hospital volume and outcomes for selected diagnostic categories. Med Care 1984;22: Greenfield S, Aronow HU, Elashoff RM, et al. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 1988;260: Jencks SF, Williams DK, Kay TL. Assessing hospitalassociated deaths from discharge data. The role of length of stay and comorbidities. JAMA 1988;260: Jencks SF, Daley J, Draper D, Thomas N, Lenhart G, Walker J. Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA 1988;260: Notice From the American Board of Thoracic Surgery The American Board of Thoracic Surgery began its recertification process in Diplomates interested in participating in this examination should maintain a documented list of the operations they performed during the year prior to application for recertification. This practice review should consist of 1 year s consecutive major operative experiences. (If more than 100 cases occur in 1 year, only 100 need to be listed.) They should also keep a record of their attendance at approved postgraduate medical education activities for the 2 years prior to application. A minimum of 100 hours of approved CME activity is required. In place of a cognitive examination, candidates for recertification will be required to complete both the general thoracic and cardiac portions of the SESATS VI syllabus (Self-Education/Self-Assessment in Thoracic Surgery). It is not necessary for candidates to purchase SESATS VI booklets prior to applying for recertification. SESATS VI booklets will be forwarded to candidates after their applications have been accepted. Diplomates whose 10-year certificates will expire in 2000 may begin the recertification process in This new certificate will be dated 10 years from the time of expiration of the original certificate. Recertification is also open to any diplomate with an unlimited certificate and will in no way affect the validity of the original certificate. The deadline for submission of applications is May 1, A recertification brochure outlining the rules and requirements for recertification in thoracic surgery is available upon request from the American Board of Thoracic Surgery, One Rotary Center, Suite 803, Evanston, IL by The Society of Thoracic Surgeons Ann Thorac Surg 1997;64: /97/$17.00 Published by Elsevier Science Inc PII S (97)

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery

A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,

More information

Risk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery

Risk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen

More information

Risk Stratification Using The Society of Thoracic Surgeons Program

Risk Stratification Using The Society of Thoracic Surgeons Program Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic

More information

Coronary artery bypass graft (CABG) operations have

Coronary artery bypass graft (CABG) operations have Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care

More information

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England

Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.

More information

Intra-operative Echocardiography: When to Go Back on Pump

Intra-operative Echocardiography: When to Go Back on Pump Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Transfusion & Mortality. Philippe Van der Linden MD, PhD Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:

More information

Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery

Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.06, pp 203-208, 2018 Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

BUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting

BUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting BUN as a Risk Factor for Mortality After Coronary Artery Bypass Grafting Arthur J. Hartz, MD, PhD, Evelyn M. Kuhn, PhD, Kenneth L. Kayser, MS, and W. Dudley Johnson, MD Department of Family and Communitv

More information

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,

More information

Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm

Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Nephrol Dial Transplant (2003) 18: 77 81 Original Article Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Bjørn O. Eriksen 1, Kristel R.

More information

Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005

Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to

More information

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications

Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University

More information

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed

More information

Cardiac surgery remains a very complex area for outcome

Cardiac surgery remains a very complex area for outcome Mortality Prediction in Cardiac Surgery Patients Comparative Performance of Parsonnet and General Severity Systems J. Martínez-Alario, MD; I.D. Tuesta, MD; E. Plasencia, MD; M. Santana, MD; M.L. Mora,

More information

Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting

Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Tuula S. O. Kurki, MD, and Matti Kataja, PhD Heart Center, Deaconess Hospital, and National Public Health Institute,

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Acute kidney injury prediction following elective cardiac surgery: AKICS Score

Acute kidney injury prediction following elective cardiac surgery: AKICS Score original article http://www.kidney-international.org & 2007 International Society of Nephrology Acute kidney injury prediction following elective cardiac surgery: AKICS Score H Palomba 1, I de Castro 1,

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery

Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery JUAN S. JARAMILLO, MD Cardiovascular Surgery Clinica CardioVID Medellin Colombia DISCLOSURE INFORMATION Consultant

More information

TSDA ACGME Milestones

TSDA ACGME Milestones TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short

More information

Emergency Intraoperative Echocardiography

Emergency Intraoperative Echocardiography Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

ery: Comparison of Predicted and Observed Resu ts

ery: Comparison of Predicted and Observed Resu ts Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,

More information

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative

More information

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at

More information

EXTRACORPOREAL MEMBRANE OXYGENATION

EXTRACORPOREAL MEMBRANE OXYGENATION Outcome in Patients Who Require Venoarterial Extracorporeal Membrane Oxygenation Support After Cardiac Surgery Hesham A. Elsharkawy, MD, MSc,* Liang Li, PhD, Wael Ali Sakr Esa, MD, Daniel I. Sessler, MD,

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

STS CABG Composite Quality Rating. Participant STS Period Ending 12/31/2016

STS CABG Composite Quality Rating. Participant STS Period Ending 12/31/2016 STS CABG Composite Quality Rating Quality Participant Score STS Mean Participant Distribution of Participant Scores Domain (98% CI) Participant Score Rating = STS Mean Jan 06 - Dec 06 Overall Jan 06 -

More information

Intraoperative and Postoperative Risk Factors for Respiratory Failure After Coronary Bypass

Intraoperative and Postoperative Risk Factors for Respiratory Failure After Coronary Bypass Intraoperative and Postoperative Risk Factors for Respiratory After Coronary Bypass Charles C. Canver, MD, and Jyotirmay Chanda, MD, PhD Division of Cardiothoracic Surgery, The Heart Institute, Albany

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?

Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery CVICU EXAM 1111 North 3rd Street Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery 1. Nursing standards for a patient on an IABP device include: a. Know results of

More information

Blood Management of the Cardiac Patient in the Postoperative Period

Blood Management of the Cardiac Patient in the Postoperative Period Blood Management of the Cardiac Patient in the Postoperative Period Al Stammers, MSA, CCP, Eric Tesdahl, PhD Andy Stasko MS, CCP, RRT, Linda Mongero, BS, CCP, Sam Weinstein, MD, MBA Goal To examine the

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

Coronary artery bypass grafting (CABG) is one of the most intensely scrutinized

Coronary artery bypass grafting (CABG) is one of the most intensely scrutinized Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie

More information

ACS-NSQIP 2015 Julietta Chang MD, Ali Aminian MD, Stacy A Brethauer MD, Philip R Schauer MD Bariatric and Metabolic Institute

ACS-NSQIP 2015 Julietta Chang MD, Ali Aminian MD, Stacy A Brethauer MD, Philip R Schauer MD Bariatric and Metabolic Institute ACS-NSQIP 2015 Julietta Chang MD, Ali Aminian MD, Stacy A Brethauer MD, Philip R Schauer MD Bariatric and Metabolic Institute Disclosures Authors: No disclosures ACS-NSQIP Disclaimer: The American College

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

12 RANUCCI ET AL Ann Thorac Surg HEMODILUTION DURING CPB AND MORBIDITY RISK 2010;89:11 8 Abbreviations and Acronyms CI confidence interval CPB cardiop

12 RANUCCI ET AL Ann Thorac Surg HEMODILUTION DURING CPB AND MORBIDITY RISK 2010;89:11 8 Abbreviations and Acronyms CI confidence interval CPB cardiop ORIGINAL ARTICLES: CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

The strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?

The strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery? Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?* Nirupama G. Talwalkar, MD, FCCP; Gerald M. Lawrie, MD, FCCP; Nan Earle, BS; and Michael E. DeBakey, MD, FCCP Background:

More information

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Heart Disease is a significant problem in the United States:

More information

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA

More information

Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage

Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark

More information

Cardiovascular Surgery. Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery

Cardiovascular Surgery. Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery Cardiovascular Surgery Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery Rajendra H. Mehta, MD, MS; Joshua D. Grab, MS; Sean M. O Brien, PhD; Charles

More information

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Outcome of elderly patients with severe but asymptomatic aortic stenosis

Outcome of elderly patients with severe but asymptomatic aortic stenosis Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress

More information

Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement

Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,

More information

Managing Hypertension in the Perioperative Arena

Managing Hypertension in the Perioperative Arena Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Severe Ischemic Early Liver Injury After Cardiac Surgery

Severe Ischemic Early Liver Injury After Cardiac Surgery Severe Ischemic Early Liver Injury After Cardiac Surgery Jai S. Raman, FRACS, Kazuhiro Kochi, MD, Hiroshi Morimatsu, MD, Brian Buxton, FRACS, and Rinaldo Bellomo, MD Departments of Cardiac Surgery, and

More information

In the United States, 97 million overweight or obese

In the United States, 97 million overweight or obese The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,

More information

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Coronary artery bypass grafting (CABG) is a temporary treatment for a Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc

More information

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87

More information

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity? Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication

More information

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;

More information

Modeling and Risk Prediction in the Current Era of Interventional Cardiology

Modeling and Risk Prediction in the Current Era of Interventional Cardiology Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.

More information

The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery

The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery The Journal of ExtraCorporeal Technology The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery Joshua B. Goldberg, MD;* Kenneth G.

More information

Copyright by ICR Publishers 2005

Copyright by ICR Publishers 2005 Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of

More information

Divisions of Cardiology and Cardiovascular Surgery, Veterans Administration Medical Center and University of Minnesota, Minneapolis, Minnesota

Divisions of Cardiology and Cardiovascular Surgery, Veterans Administration Medical Center and University of Minnesota, Minneapolis, Minnesota Comparison of Risk Scores to Estimate Perioperative Mortality in Aortic Valve Replacement Surgery Jagroop Basraon, DO, Yellapragada S. Chandrashekhar, MD, Ranjit John, MD, Adheesh Agnihotri, MD, Rosemary

More information

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031

More information

Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model

Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model Andrzej Kansy, MD, PhD, Jeffrey P. Jacobs, MD, PhD, Andrzej Pastuszko, MD, PhD, Małgorzata Mirkowicz-Małek,

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit

Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit Clinical Report Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit Journal of International Medical Research 2018, Vol. 46(3) 1254 1262! The Author(s) 2018

More information

Updated NSQIP Frailty Index

Updated NSQIP Frailty Index Updated NSQIP Frailty Index Adam P. Johnson, MD, MPH; 1 Sarah E. Koller, MD; 2 Emily A. Busch, MD; 2 Matt M. Philp, MD; 2 Howard Ross, MD; 2 Paul J DiMuzio, MD; 1 Scott W. Cowan, MD; 1 Henry A. Pitt, MD

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients

The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients The Turkish Journal of Pediatrics 2008; 50: 549-553 Original The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients Selman Vefa Yıldırım 1, Kürşad

More information

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers

The prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular

More information

A case-control study of readmission to the intensive care unit after cardiac surgery

A case-control study of readmission to the intensive care unit after cardiac surgery DOI: 0.2659/MSM.88384 Received: 202.04.24 Accepted: 203.0.25 Published: 203.02.28 A case-control study of readmission to the intensive care unit after cardiac surgery Authors Contribution: Study Design

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

THE incidence of stroke after noncardiac surgery

THE incidence of stroke after noncardiac surgery Lack of Association between Carotid Artery Stenosis and Stroke or Myocardial Injury after Noncardiac Surgery in High-risk Patients ABSTRACT Background: Whether carotid artery stenosis predicts stroke after

More information

Right Ventricular Failure: Prediction, Prevention and Treatment

Right Ventricular Failure: Prediction, Prevention and Treatment Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:

More information

Minimally Invasive Mitral Valve Repair: Indications and Approach

Minimally Invasive Mitral Valve Repair: Indications and Approach Minimally Invasive Mitral Valve Repair: Indications and Approach Juan P. Umaña, M.D. Chief Medical Officer Director, Cardiovascular Medicine FCI - Institute of Cardiology Bogota Colombia 1 Mitral Valve

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery

Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery Are Young Patients More Likely to Develop Adverse Aortic Remodeling of the Remnant Aorta Over Time? Suk Jung Choo¹, Jihoon Kim¹,

More information

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Corrective Surgery in Severe Heart Failure Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Session Objectives 1.) Identify which patients with severe

More information

Ischemic Ventricular Septal Rupture

Ischemic Ventricular Septal Rupture Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor

More information

Base deficit in the immediate postoperative period of open-heart surgery and patient outcome

Base deficit in the immediate postoperative period of open-heart surgery and patient outcome Original Research Medical Journal of the Islamic Republic of Iran.Vol. 21, No. 4, February 2008. pp. 215-222 Base deficit in the immediate postoperative period of open-heart surgery and patient outcome

More information